Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion type Assertion NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_head.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion description "[Therefore, the aim of the present study was to examine in the human neuroblastoma SH-SY5Y cell line the impact of a typical (haloperidol) and an atypical (quetiapine) antipsychotic on the expression of genes encoding the key enzymes of the antioxidant metabolism (Cu, Zn superoxide dismutase; Mn superoxide dismutase; glutathione peroxidase; catalase) and enzymes of the glutathione metabolism (gamma-glutamyl cysteine synthetase, glutathione-S-transferase, gamma-glutamyltranspeptidase, glutathione reductase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_provenance.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion evidence source_evidence_literature NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_provenance.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion SIO_000772 19101687 NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_provenance.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion wasDerivedFrom befree-20150227 NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_provenance.
- NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_assertion wasGeneratedBy ECO_0000203 NP437080.RA1o7F-YssV65I3wIHliDJ_ckPQRMzPXN_6_eQu1Ngylc130_provenance.